Atazanavir atazanavir is a structural analog of the transition state during which the bond between a phenylalanine and proline is broken. Humans do not have any enzymes that break bonds between phenylalanine and proline, so this drug will not target human enzymes. Atazanavir is available as a 150 mg capsule, 200 mg capsule, 300 mg capsule, and 50 mg oral powder packet. The 300 mg capsule should reduce pill burden, as one 300 mg capsule may replace two 150 mg capsules. Atazanavir Atazanavir, sold under the trade name Reyataz among others, is an antiretroviral medication used to treat and prevent HIV/AIDS.
Egyptian medical papyri making it the lengthiest of the medical papyri. The papyrus covers many different topics including; dermatology, digestive diseases, traumatic diseases, dentistry and gynecological conditions. It makes many references to treating ailments with spells or religious techniques. One of the most important findings of this papyrus are the references to migraines which shows the condition dates back to this time. The "Hearst Papyrus" was offered in 1901 to the Hearst Expedition in Egypt. It is dated around 2000 BC, though doubts subsist about its authenticity. It concentrated on treatments for problems dealing with the urinary system, blood, hair, and bites. It